To hear about similar clinical trials, please enter your email below
Trial Title:
A Cohort Study of Uterine Malignancies
NCT ID:
NCT05635123
Condition:
Cervical Cancer
Endometrial Cancer
Conditions: Official terms:
Endometrial Neoplasms
Study type:
Observational
Overall status:
Recruiting
Study design:
Time perspective:
Prospective
Intervention:
Intervention type:
Other
Intervention name:
No intervention
Description:
This is a prospective observational study with no intervention.
Summary:
The purposes of current study were to explore the relationship between cervical
cancer/endometrial cancer and demographic information, behavior and life style,
pregnancy-related factors, and disease history, and to study the factors affecting the
prognosis of cancers. In addition, omics tests were performed on the biological specimens
to identify the diagnostic markers and prognostic biomarkers.
Detailed description:
After being informed about the study and potential risks, all patients who meet the
eligibility requirements will be enrolled.
Criteria for eligibility:
Study pop:
The investigators establish a population cohort of 6200 women including patients with
cervical cancer or endometrial cancer, and women attending to a health check-up.
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- Age 20-75 years;
- Women with cervical cancer or endometrial cancer with a definite pathological
diagnosis for the first time;
- Women attending a health check-up;
- Obtain informed consent and sign an informed consent form.
Exclusion Criteria:
- Patients who are unable to cooperate with the investigations such as mental
disorders or cognitive impairment；
- Patients with cancer other than cervical cancer or endometrial cancer;
- Women who have received hysterectomy or pelvic radiation therapy previously.
Gender:
Female
Minimum age:
20 Years
Maximum age:
75 Years
Healthy volunteers:
No
Locations:
Facility:
Name:
Women's hospital school of medicine zhejiang university
Address:
City:
Hangzhou
Zip:
310000
Country:
China
Status:
Recruiting
Contact:
Last name:
Hui Wang, PhD
Phone:
057189998857
Email:
wang71hui@zju.deu.cn
Start date:
September 15, 2023
Completion date:
December 1, 2030
Lead sponsor:
Agency:
Women's Hospital School Of Medicine Zhejiang University
Agency class:
Other
Source:
Women's Hospital School Of Medicine Zhejiang University
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05635123
